Home > Share Market > Stocks > Orchid pharma > Financial Statements> ORCHPHARMA Profit & Loss

Orchid Pharma Ltd Financial Statements

Profit & Loss Statement of Orchid Pharma Ltd

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar ( In .Cr) Mar-2022 Mar-2021 Mar-2020 Mar-2018
Revenue 560 450 508 683
yoy growth (%) 24.30 (11) (26) (14)
Raw materials (314) (229) (243) (350)
As % of sales 56 50.80 47.90 51.30
Employee costs (63) (67) (85) (86)
As % of sales 11.30 14.90 16.70 12.60
Other costs (130) (105) (205) (231)
As % of sales 23.20 23.30 40.40 33.80
Operating profit 53.10 49.80 (25) 15.70
OPM 9.50 11.10 (5) 2.30
Depreciation (87) (109) (126) (133)
Interest expense (32) (51) (4.20) (302)
Other income 9 15.20 24.50 20.30
Profit before tax (57) (95) (131) (399)
Taxes -- -- -- 46.20
Tax rate -- -- -- (12)
Minorities and other 54.90 (21) -- --
Adj. profit (2) (117) (131) (353)
Exceptional items -- -- -- --
Net profit (2) (117) (131) (353)
yoy growth (%) (98) (11) (63) (29)
NPM (0.30) (26) (26) (52)

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000